Reaction

Dermatitis Acneiform reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,972 reports · 163 co-occurring drugs

As of the last recalculation, Dermatitis Acneiform appears in 5,972 FAERS reports alongside 163 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 282.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Panitumumab	1,048	282.6	302.9
Cetuximab	852	110.4	113.5
Erlotinib	188	69.8	71.2
Erlotinib Hydrochloride	231	66.9	68.1
Irinotecan Hydrochloride	136	37.7	38.1
Fluorouracil Cream, 0.5%	688	35.4	35.7
Fluorouracil	689	35.0	35.3
Gefitinib	84	32.9	33.2
Oxaliplatin	603	31.4	31.6
Trametinib	182	27.0	27.2
Vemurafenib	82	24.1	24.3
Encorafenib	65	23.1	23.3
Lapatinib	94	21.4	21.6
Leucovorin Calcium	96	17.8	17.9
Dabrafenib	78	13.1	13.1
Granisetron Hydrochloride	38	12.8	12.8
Pemetrexed	75	12.3	12.4
Pertuzumab	92	12.0	12.0
Osimertinib	107	11.8	11.9
Granisetron	35	11.7	11.7
Minocycline	38	11.4	11.5
Atropine	27	11.4	11.4
Ado-Trastuzumab Emtansine	26	10.8	10.8
Dexamethasone Sodium Phosphate	29	10.0	10.0
Atropine Sulfate	29	9.4	9.4
Clindamycin Phosphate	87	9.2	9.2
Pemetrexed Disodium	98	9.1	9.1
Doxycycline Hyclate	168	8.9	8.9
Magnesium Sulfate Heptahydrate	33	8.9	8.9
Doxycycline	168	8.8	8.8
Bevacizumab	298	8.8	8.8
Magnesium Sulfate In Water For	31	8.5	8.5
Magnesium Sulfate	31	8.3	8.3
Clindamycin	63	7.8	7.8
Trastuzumab	149	7.7	7.7
Fosaprepitant Dimeglumine	30	7.6	7.7
Regorafenib	24	7.2	7.2
Docetaxel Anhydrous	135	7.1	7.1
Docetaxel	135	7.1	7.1
Aprepitant	37	7.0	7.0
Capecitabine	179	7.0	7.0
Cisplatin	151	6.9	6.9
Gemcitabine Hydrochloride	102	6.8	6.8
Rabeprazole	41	6.5	6.5
Prochlorperazine Maleate	17	6.4	6.5
Tofacitinib Citrate	23	6.1	6.1
Chlorhexidine Gluconate	16	6.1	6.1
Carboplatin	212	6.0	6.0
Sirolimus	23	6.0	6.0
Sorafenib	35	5.9	5.9
Everolimus Tablets	28	5.8	5.9
Tretinoin	13	5.6	5.6
Cabozantinib	70	5.1	5.1
Paclitaxel	139	5.0	5.0
Paclitaxel (Aibumin-Bound)	114	4.9	4.9
Gemcitabine	54	4.8	4.8
Doxyclycline Hyclate	23	4.7	4.7
Cimetidine	13	4.7	4.7
Loperamide Hydrochloride And Dimethicone	43	4.7	4.7
Loperamide Hcl	17	4.6	4.6
Clobetasol Propionate Ointment Usp, 0.05%	13	4.4	4.4
Clobetasol Propionate	13	4.4	4.4
Magnesium Oxide	52	4.4	4.4
Diphenoxylate Hydrochloride And Atropine Sulfate	17	4.3	4.3
Anti-Thymocyte Globulin (Rabbit)	10	4.3	4.3
Loperamide Hydrochloride	54	4.2	4.2
Diphenhydramine Hydrochloride	181	3.9	3.9
Ketoconazole	19	3.8	3.8
Everolimus	55	3.8	3.8
Nystatin	29	3.7	3.7
Nystatin Ointment	27	3.6	3.6
Miconazole Nitrate	9	3.6	3.6
Nystatin Cream	27	3.6	3.6
Triamcinolone Acetonide Ointment Usp, 0.05%	24	3.6	3.6
Trifluridine And Tipiracil	11	3.6	3.6
Ketoconazole Foam	15	3.5	3.5
Ursodiol	22	3.5	3.5
Ketoconazole Cream, 2%	15	3.5	3.5
Amlodipine Besylate And Valsartan	11	3.5	3.5
Nivolumab	95	3.5	3.5
Rabeprazole Sodium	27	3.5	3.5
Cefazolin	9	3.4	3.4
Atezolizumab	38	3.4	3.4
Mercaptopurine	17	3.4	3.4
Loperamide Hydrochloride Oral	10	3.4	3.4
Phytonadione	8	3.3	3.3
Desloratadine	10	3.3	3.3
Filgrastim	34	3.2	3.2
Infliximab-Dyyb	26	3.1	3.1
Atovaquone	7	3.0	3.0
Fexofenadine Hcl	8	3.0	3.0
Fondaparinux Sodium	7	3.0	3.0
Exemestane	18	2.9	2.9
Ipilimumab	36	2.9	2.9
Cefazolin Sodium	10	2.9	2.9
Zoledronic Acid	33	2.9	2.9
Ondansetron Hydrochloride	100	2.9	2.9
Triamcinolone Acetonide	25	2.8	2.8
Diphenhydramine Hcl	9	2.8	2.8
Mesalamine	45	2.8	2.8
Metronidazole Topical	38	2.8	2.8
Ondansetron	84	2.7	2.7
Ondansetron Tablets	84	2.7	2.7
Dapsone	8	2.6	2.6
Goserelin	10	2.6	2.6
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	22	2.5	2.5
Daspone	7	2.5	2.5
Dapsone Gel, 5%	7	2.5	2.5
Upadacitinib	57	2.5	2.5
Itraconazole	8	2.4	2.4
Pitavastatin Calcium	7	2.4	2.4
Rocuronium Bromide	8	2.4	2.4
Vismodegib	6	2.4	2.4
Lenvatinib	22	2.3	2.3
Ursosiol	13	2.3	2.3
Famotidine	78	2.3	2.3
Temozolomide	14	2.3	2.3
Sunitinib Malate	26	2.3	2.3
Norepinephrine	7	2.3	2.3
Letrozole	40	2.3	2.3
Prochlorperazine	18	2.3	2.3
Thiotepa	6	2.2	2.2
Dasatinib	23	2.2	2.2
Ruxolitinib	42	2.1	2.1
Nilotinib	17	2.0	2.0
Norepinephrine Bitartrate	8	1.9	1.9
Crizotinib	7	1.9	1.9
Letrozole Tablets	26	1.9	1.9
Ribociclib	17	1.9	1.9
Dexamethasone 1.5 Mg	154	1.9	1.9
Dexamethasone	154	1.8	1.8
Ibrutinib	42	1.8	1.8
Bendamustine Hcl	8	1.8	1.8
Entecavir	6	1.8	1.8
Imatinib	9	1.8	1.8
Fexofenadine Hydrochloride	11	1.8	1.8
Nintedanib	15	1.7	1.7
Vedolizumab	41	1.7	1.7
Isotretinoin	23	1.6	1.6
Sarilumab	12	1.6	1.6
Pazopanib Hydrochloride	12	1.5	1.5
Nevirapine	4	1.5	1.5
Pembrolizumab	46	1.5	1.5
Elexacaftor, Tezacaftor, And Ivacaftor	5	1.4	1.4
Fam-Trastuzumab Deruxtecan-Nxki	4	1.4	1.4
Pegfilgrastim	39	1.4	1.4
Tofacitinib	65	1.2	1.2
Aflibercept	11	1.2	1.2
Ixazomib	10	1.2	1.2
Alpelisib	3	1.2	1.2
Avapritinib	4	1.2	1.2
Bimekizumab	6	1.0	1.0
Dupilumab	125	0.9	0.9
Axitinib	5	0.9	0.9
Apalutamide	3	0.9	0.9
Abemaciclib	5	0.9	0.9
Durvalumab	5	0.9	0.9
Abaloparatide	7	0.8	0.8
Dornase Alfa	4	0.7	0.7
Pirfenidone	7	0.6	0.6
Nirmatrelvir And Ritonavir	6	0.4	0.4
Evolocumab	18	0.4	0.4
Adapalene	14	0.3	0.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.